Stay informed with the latest litigation news. Explore now

IP Verse

Cambridge Enterprise patent opposition analysis

Latest patents of Cambridge Enterprise opposed by its competitors

Explore Cambridge Enterprise's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 28, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3166628
Jul 26, 2023Therapeutic Use Of Bone Morphogenetic Proteins1
EP3545079
Apr 6, 2022Controllable Transcription1
EP3183336
Nov 25, 2020Resetting Pluripotent Stem Cells1
EP2564467
Oct 28, 2020Rfid Tag Interrogation Systems1
EP2825646
Aug 7, 2019Methods For Obtaining Liquid From A Solid Phase1
EP2364480
Mar 7, 2018Substance Monitoring And Control In Human Or Animal Bodies1

Top competitors of Cambridge Enterprise

Top competitors of Cambridge Enterprise based on patent oppositions.